Jiménez-Fonseca, Paula; Carmona-Bayonas, Alberto; Hernández, Raquel; Custodio, Ana; Cano, Juana-María; Lacalle, Alejandra; Echavarría, Isabel; Macías, Ismael; Mangas, Monserrat; Visa, Laura; Buxo, Elvira; Álvarez-Mancenido, Felipe; Viudez, Antonio; Pericay, Carles; Azkarate, Aitor; Ramchandani, Avinash; López, Carlos; Martínez-de-Castro, Eva; Fernández-Montes, Ana; Longo, Federico; Sánchez-Bayona, Rodrigo; Limon, María-Luisa; Díaz-Serrano, Asun; Martín-Carnicero, Alfonso; Arias, David; Cerdá, Paula; Rivera, Fernando; Vieitez, José-María; Sánchez-Cánovas, Manuel; Garrido, M; Gallego, J
(NATURE PUBLISHING GROUP, 2017-09-05)
BACKGROUND: The choice of chemotherapy in HER2-negative gastric cancer is based on centre's preferences and adverse effects profile. No schedule is currently accepted as standard, nor are there any factors to predict ...